Notably, sorted CD34+ cells which marks the healthy stem cells from 17 healthy donors3 had markedly lower levels of IFNγ signaling scores than did those from AML patients (Fig. 1E), suggesting that IFNγ pathway signaling is a predominant feature in AML. The gene discussed is IFNG; the disease is acute myeloid leukemia.